Updated:
Health Velocity Capital
Founded in 2016 by Ursheet Parikh and Rylan Bowers, Health Velocity Capital operates from San Francisco with a concentrated thesis that healthcare's...
Health Velocity Capital
Founded in 2016 by Ursheet Parikh and Rylan Bowers, Health Velocity Capital operates from San Francisco with a concentrated thesis that healthcare's fragmentation creates alpha for specialists. Parikh brought experience from NEA and Scale Venture Partners, while Bowers arrived from GE Ventures, giving the founding pair exposure across enterprise technology and corporate innovation. The firm deploys growth-stage capital into healthcare software and tech-enabled services, targeting companies that improve access, affordability, and consumer experience. Its portfolio spans digital health platforms, care delivery innovations, and enterprise workflow tools serving payers and providers. Confirmed positions include Cedar, the patient billing and engagement platform (per Axios, 2021), and Ribbon Health, an API-driven provider data platform (per the firm, 2020). The geographic footprint centers on the US market, where regulatory complexity and misaligned incentives create barriers that generalist funds rarely navigate effectively. Health Velocity Capital maintains a network of strategic limited partners — executives from major health plans, health systems, and healthcare technology companies — who provide market intelligence and distribution relationships. In January 2023, the firm held a final close on Health Velocity Capital III LP, securing $300 million in commitments (per PitchBook, 2023), a signal of continued LP conviction in its tightly scoped mandate. The fund targets minority stakes and board seats in companies typically generating between $5 million and $20 million in revenue. What distinguishes Health Velocity structurally is its intentional reliance on an operating network of healthcare CIOs, CEOs, and payer executives who co-invest and act as commercial partners for portfolio companies. This network effect functions as an informal distribution channel, reducing the go-to-market risk that sinks many health-tech startups. The firm has not disclosed expanding beyond its single San Francisco office, maintaining a deliberate geographic focus consistent with its thesis that deep, narrow expertise compounds better than scaling headcount.
General information
Firm type
Private Equity
Year founded
2016
AUM
$200M - $500M (Altss estimate)
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Principals
Ursheet Parikh
Co-Founder & Managing Partner
Rylan Bowers
Co-Founder & Managing Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Health Velocity Capital?
Investment decisions are led by co-founders and managing partners Ursheet Parikh and Rylan Bowers. Parikh previously invested at NEA and Scale Venture Partners, while Bowers held a venture role at GE Ventures. The lean partnership structure means no investment committee filters exist beyond the two managing partners, an architecture designed for speed in competitive growth-stage processes.
How does Health Velocity Capital source proprietary deal flow?
The firm's core sourcing advantage stems from its strategic LP base, which includes senior executives at large health plans, health systems, and healthcare technology companies. These relationships provide early visibility into emerging companies solving operational pain points inside payer and provider organizations. The firm also leverages its portfolio-founder network and the healthcare CIO community that Bowers cultivated during his tenure at GE Ventures.
What investment stages does Health Velocity Capital typically target?
Health Velocity Capital is a growth-stage investor, typically leading Series B and C rounds. The firm looks for companies generating between $5 million and $20 million in revenue that have demonstrated product-market fit inside healthcare enterprises and need capital to scale commercial teams and expand into adjacent customer segments.
How is Health Velocity Capital related to its strategic LPs?
Unlike a traditional LP-GP arrangement, the firm's healthcare executive LPs serve as an informal advisory and commercial network. They provide market intelligence on procurement cycles, regulatory shifts, and competitive dynamics from inside payer and provider organizations. Several LPs have facilitated pilot programs and enterprise introductions for portfolio companies, though the firm publicly discloses no formal revenue-sharing or fee arrangements with its LP network.
What sectors does Health Velocity Capital explicitly avoid?
The firm does not invest in therapeutics, medical devices, diagnostics, or biotech platforms. Its mandate explicitly excludes FDA-regulated clinical products and instead concentrates on software, data platforms, and tech-enabled service models that improve healthcare administration, payment, and consumer access without taking regulatory risk on clinical outcomes.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: